Accepted for/Published in: JMIR Diabetes
Date Submitted: Feb 5, 2021
Date Accepted: May 13, 2021
Date Submitted to PubMed: May 17, 2021
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Change in glycemic control for patients enrolled in a membership-based primary care program: longitudinal observational study
ABSTRACT
Background:
Both primary care and digital therapeutics have been shown to improve the care of patients with diabetes.
Objective:
This observational study examines the change in diabetes control for patients enrolled in a membership-based primary care service.
Methods:
Using a diabetes registry, we analyzed change in HbA1c for patients with uncontrolled diabetes mellitus (initial HbA1c >9%). All patients had access to a technology-enhanced primary care practice built on the chronic care model.
Results:
The registry included 621 patients diagnosed with uncontrolled diabetes. All patients had at least two HbA1c measurements, with the average time between the first and last measurement of 1.2 years (SD=0.4). The average starting value of HbA1c was 10.7, which decreased to 8.7, corresponding to a -2.03 (p<0.001) reduction. Secondary analyses showed statistically significant reductions in total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides.
Conclusions:
Patients with initially uncontrolled diabetes who undergo care in a technology-enhanced primary care practice have long-term clinically meaningful reductions in HbA1c.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.